Akari Therapeutics

-$0.01 (-0.60%) As of 6:22 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKTX and other ETFs, options, and stocks.

About AKTX

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor.

CEO
Clive Stuart Richardson
Employees
8
Headquarters
London, Greater London
Founded
2004

AKTX Key Statistics

Market cap
78.54M
Price-Earnings ratio
—
Dividend yield
—
Average volume
121.87K
High today
$1.67
Low today
$1.56
Open price
$1.67
Volume
38.61K
52 Week high
$4.21
52 Week low
$1.38

AKTX Earnings

-$0.01
-$0.01
-$0.00
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Dec 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure